Calcium channel stabilisers therapy(ARMGO Pharma)

N/A

Report date: 2023/12/26 18:02:51
NME

Base Information

Drug NameCalcium channel stabilisers therapy(ARMGO Pharma)
Drug Alias NameRyanodine receptor calcium-release channel (RyR) modulators therapy(ARMGO Pharma)RycalsS 107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRyanodine receptor calcium release channel modulators
TargetsRyanodine receptor calcium release channel
Therapy Area/IndicationsHeart FailureSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRyCarma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRyCarma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHeart FailureSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A